Nonprofit · EIN 45-2210161
BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA
Tax-exempt · OCEANSIDE, CA 92056
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990-EZ | $141,627 | $136,871 | $4,756 | $55,641 | $46,031 | $9,610 |
| December 31, 2023 | 990 | $208,249 | $188,995 | $19,254 | $60,330 | $55,476 | $4,854 |
Financial details: 990-EZ for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $21,823
- Other revenue
- $119,804
Expenses
- Compensation of officers, directors and key employees
- $29,482
- Salaries, compensation and benefits (total)
- $17,109
- Professional fees and payments to contractors
- $5,106
- Occupancy
- $106,092
- Printing, publications and postage
- $362
- Other expenses
- $8,202
Balance sheet and other
- Total assets, start of year
- $60,381
- Total assets, end of year
- $55,641
- Total liabilities, end of year
- $46,031
- Net assets, end of year
- $9,610
- Cash, savings and investments
- $53,869
- Gross receipts
- $141,627
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990-EZ for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| SALLY SARAWAR | PRESIDENT AND CEO | 16 | $29,482 |
| PETER DIAS | CFO | 4 | $0 |
| CRAIG JACKSON | DIRECTOR | 0.3 | $0 |
| LEMAN YEL | DIRECTOR | 0.3 | $0 |
| MICHAEL GISKE | DIRECTOR | 0.3 | $0 |
990 for the year ended December 31, 2023: 5 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| DR SALLY SARAWAR | PRESIDENT AND CEO Officer | 20 | $34,683 |
| DR CRAIG JACKSON | CHAIRMAN OF BOARD OF DIREC Trustee or director | 0.5 | $0 |
| DR LEMAN YEL | DIRECTOR Trustee or director | 0.3 | $0 |
| DR PETER DIAS | CFO Trustee or director, Officer | 20 | $0 |
| MR MICHAEL GISKE | DIRECTOR Trustee or director | 0.5 | $0 |
Address and contacts
- Address (IRS master file)
- 4225H OCEANSIDE BLVD SUITE 273, OCEANSIDE, CA 92056-3471
- In care of
- % SALLY SARAWAR
- Mailing address (990-N for 2013)
- 4263 Oceanside Blvd Ste 106-159, Oceanside CA 92056
- Principal officer (990-N for 2013)
- Sally Sarawar, 4263 Oceanside Blvd Ste 106-159, Oceanside CA 92008
- Signed the 990-EZ
- SALLY SARAWAR, PRESIDENT
- Phone
- (888) 723-5830
- Website
- www.bri-sc.org
- Return prepared by
- MANN & ASSOCIATES APC
California records
California keeps its own records of charities and corporations. Search them by EIN 45-2210161 or by the name BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA.
- Attorney General, Registry of Charities and Fundraisers
- Registration status and filed reports (CT-TR-1, RRF-1)
- Secretary of State, bizfile Online
- Corporation status, entity number, agent for service
- Franchise Tax Board
- Entity status letter (state tax exemption, good standing)
Mission
THE MISSION OF THIS ORGANIZATION IS TO CONDUCT BASIC RESEARCH TO ADVANCE OUR UNDERSTANDING OF THE FUNDAMENTAL MECHANISMS OF NORMAL BIOLOGICAL PROCESSES AND HOW THOSE DIFFER IN DISEASE STATES. OUR GOAL IS TO IDENTIFY NEW WAYS TO DIAGNOSE, PREVENT OR TREAT HUMAN DISEASE. OUR AREAS OF INTEREST INCLUDE CANCER, DIABETES, OSTEOARTHRITIS, ASTHMA AND OTHER RESPIRATORY DISEASES, TRANSPLANTATION, CHRONIC FATIGUE SYNDROME AND INFECTIOUS DISEASES.
Program accomplishments
- VIRAL IMMUNOLOGYTHE OBJECTIVE OF THIS PROGRAM IS TO CONDUCT RESEARCH INTO THE MECHANISMS BY WHICH THE IMMUNE SYSTEM PROTECTS AGAINST VIRAL INFECTIONS. THIS RESEARCH WILL HELP US TO DEVELOP BETTER VACCINES AND THERAPEUTIC AGENTS FOR VIRAL INFECTIONS. THIS PROGRAM INCLUDES PRE-CLINICAL WORK ON A NOVEL UNIVERSAL INFLUENZA VACCINE, THE MECHANISM BY WHICH IT PROTECTS AGAINST MULTIPLE STRAINS OF INFLUENZA AND WHETHER THE VACCINE PROTECTS AGAINST SECONDARY BACTERIAL INFECTIONS OFTEN INCREASE MORTALITY FROM INFLUENZA. WE ARE ALSO INVESTIGATING NOVEL VACCINE ADJUVANTS AND WHY IMMUNE RESPONSES TO CERTAIN VACCINES WANE OVER TIME. DIABETESTHE GOAL OF THIS PROGRAM IS TO IDENTIFY UNIQUE EVENTS AND MOLECULAR PATHWAYS THAT CAN TRIGGER THE AUTOREACTIVE T CELLS TO CAUSE DESTRUCTION OF THE PANCREATIC ISLETS IN TYPE 1 DIABETES. THE ROLE OF EXOSOMES AND NOVEL SELF-ANTIGENS ENCODED BY ENDOGENOUS RETROVIRUSES IS A MAJOR FOCUS OF THIS STUDY. OUR FUNDING FOR THESE PROGRAMS LAPSED IN 2022 AND WE HAD TO SUBLEASE SOME OF OUR OFFICE AND LABORATORY SPACE, TO A COMPANY DEVELOPING NOVEL CANCER DRUGS. WE WERE ABLE TO CONTINUE WORKING ON OUR PROGRAMS USING EXISTING RESOURCES, WHILE ATTEMPTING TO SECURE NEW GRANT FUNDING. WE WERE SUCCESSFUL IN OBTAINING FUNDING; HOWEVER, THE NEW GRANT FUNDING DID NOT START UNTIL MARCH 2023.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990-EZ on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 45-2210161
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 2012
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H92)
- Assets (IRS master file)
- $55,641
- Income (IRS master file)
- $141,627
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990-EZ | December 2024 | $141,627 | $136,871 | $55,641 | XML |
| 990 | December 2023 | $208,249 | $188,995 | $60,330 | XML |
| 990-EZ | December 2022 | – | – | – | IRS |
| 990-EZ | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
| 990 | December 2017 | – | – | – | IRS |
| 990-N for 2013 Officer: Sally Sarawar | December 31, 2013 | ≤ $50,000 receipts | – | – | e-Postcard |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 45-2210161).
Questions about BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA
- What is the EIN of BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA?
- The employer identification number (EIN) of BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA is 45-2210161.
- Is BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 2012.
- Are donations to BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA last file with the IRS?
- The latest return in the IRS public files is the 990-EZ for the year ended December 2024.
- Who is the principal officer of BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA?
- The 990-N for 2013 names Sally Sarawar.
- Who are the officers and directors of BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA?
- The 990-EZ for the year ended December 31, 2024 lists 5 people; 1 received compensation from the organization, the highest $29,482 (SALLY SARAWAR, PRESIDENT AND CEO).
- How much revenue does BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA have?
- On its 990-EZ for the year ended December 31, 2024 it reported revenue of $141,627, expenses of $136,871 and total assets of $55,641 at year end.
Other nonprofits in OCEANSIDE
- INTERNATIONAL COALITION FOR THE ADVANCEMENT OF NEUROLOGY ICAN EIN 20-3616873 · last filed 990-N for 2025
- FRONTWAVE CREDIT UNION EIN 95-1820763 · last filed 990 for 2024
- T E R I INC EIN 95-3532129 · last filed 990 for 2025
- SIATECH INC EIN 20-0898502 · last filed 990 for 2025
- BROTHER BENNO FOUNDATION INC EIN 33-0051575 · last filed 990 for 2025
- BEFORE AFTER SCHOOL ENRICHMENT INC EIN 46-0573996 · last filed 990 for 2025
- TRI-CITY HOSPITAL FOUNDATION EIN 95-6131483 · last filed 990 for 2025
- VISIT OCEANSIDE INC EIN 27-2596227 · last filed 990 for 2025